Melanoma | Tumor

Weeks of TIL Therapy ‘Buys Years’ to Next Melanoma Treatment, Expert Says

February 22nd 2024, 8:00pm

Article

Treatment with Amtagvi, a TIL therapy recently approved for advanced melanoma, includes a three-week hospital stay upfront, but may lead to years of monitoring without more treatment needed, an expert explained.

Cancer Vaccine ‘Closer Than We Ever Thought,’ 2025 Availability Possible

February 20th 2024, 8:00pm

Article

Personalized cancer vaccines are on the horizon and could be available for some patient populations as soon as next year, one expert said.

Cancer Vaccine Could Go ‘Above and Beyond Standard of Care’ For Patients

February 15th 2024, 8:00pm

Article

Moderna and Merck have initiated V940-001, a phase 3 study evaluating vaccine mRNA-4157 and anti-PD-1 therapy Keytruda as postsurgical treatment for stage 2B to 4 melanoma.

Sarah Ferguson Diagnosed With Melanoma, Selena Gomez Responds to a Fan With Cancer and More

January 26th 2024, 4:14pm

Article

From the Duchess of York receiving a skin cancer diagnosis to Selena Gomez contacting a fan with stage 4 disease, here’s what is happening in the oncology space this week.

Rare Immune Cell May Predict Immunotherapy Response in Melanoma

January 7th 2024, 3:00pm

Article

Vd1-gd T cells, a rare type of immune cell, have been found to potentially predict how likely it is that certain patients with advanced skin cancer will be responsive to treatment via immunotherapy, according to recently published research.

Basketball Player Eric Montross Dies From Cancer, Teddi Mellencamp Reveals Post-Treatment Scars and More

December 22nd 2023, 4:00pm

Article

As ‘Big Bang Theory’ star Kate Micucci announced that she is cancer-free and ‘Married at First Sight’ dating coach Mel Schilling announced her cancer diagnosis, here is what’s happening in the oncology space this week.

Cancer Vaccine Plus Keytruda Reduces Risk of Recurrence or Death in Melanoma

December 15th 2023, 10:00pm

Article

Patients with advanced-stage melanoma continue to experience reduced risk of recurrence or death following treatment with a combination of mRNA vaccine mRNA-4157 (V940) and Keytruda, an anti-PD-1 therapy, according to recent study findings.

Cancer Caregiving News From 2023

November 28th 2023, 10:00pm

Article

In honor of National Family Caregiver’s Month, CURE® highlights some of the most important news in 2023.

Coping With Mental Health During a Cancer Diagnosis

November 24th 2023, 10:00pm

Article

Melanoma as a Medical Student

November 22nd 2023, 10:00pm

Article